Spring Bank Ph CS (SBPH) Stock Price, Forecast & Analysis
USA - NASDAQ:SBPH -
SBPH Key Statistics, Chart & Performance
The current stock price of SBPH is 1.21 null. In the past month the price decreased by -4.72%. In the past year, price decreased by -59.8%.
SBPH Latest News, Press Relases and Analysis
About SBPH
Company Profile
Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including hepatitis B virus. Spring Bank Pharmaceuticals, Inc. is based in Hopkinton, United States.
Company Info
Spring Bank Ph CS
35 PARKWOOD DRIVE SUITE 210
HOPKINTON MA 01748
CEO: Martin Driscoll
Phone: 508-473-5993
Spring Bank Ph CS / SBPH FAQ
What does Spring Bank Ph CS do?
Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including hepatitis B virus. Spring Bank Pharmaceuticals, Inc. is based in Hopkinton, United States.
What is the stock price of Spring Bank Ph CS today?
The current stock price of SBPH is 1.21 null.
Does Spring Bank Ph CS pay dividends?
SBPH does not pay a dividend.
What is the ChartMill rating of Spring Bank Ph CS stock?
SBPH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Should I buy SBPH stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SBPH.
What is the market capitalization of SBPH stock?
Spring Bank Ph CS (SBPH) has a market capitalization of 20.89M null. This makes SBPH a Nano Cap stock.
SBPH Technical Analysis
SBPH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SBPH. SBPH has a bad profitability rating. Also its financial health evaluation is rather negative.
SBPH Financial Highlights
Over the last trailing twelve months SBPH reported a non-GAAP Earnings per Share(EPS) of -1.74. The EPS decreased by -8.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -100.99% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |